SCHEMBL31205

SCHEMBL31205

CCS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 16/20 0.88
PIK3CD O00329 15/20 0.88
PIK3CB P42338 13/20 0.88
PIK3CG P48736 12/20 0.88
PIK3C2A O00443 1/20 0.88
PLK4 O00444 1/20 0.88
PIK3R2 O00459 1/20 0.88
PIK3C2B O00750 1/20 0.88
GAK O14976 1/20 0.88
EPHB6 O15197 1/20 0.88
DAPK3 O43293 1/20 0.88
STK16 O75716 1/20 0.88
PIK3C2G O75747 1/20 0.88
NTRK1 P04629 1/20 0.88
NQO2 P16083 1/20 0.88
CSNK2A2 P19784 1/20 0.88
JAK1 P23458 1/20 0.88
PIK3R1 P27986 1/20 0.88
TYK2 P29597 1/20 0.88
AKT1 P31749 1/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pictilisib SCHEMBL14859338 0.94 PIK3CA (1.00) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
Pictilisib SCHEMBL29375636 0.94 PIK3CA (1.00) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
Pictilisib SCHEMBL29387739 0.94 PIK3CA (1.00) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
Pictilisib SCHEMBL190812 0.94 PIK3CA (1.00) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
SCHEMBL190211 0.93 PIK3CA (0.87) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
SCHEMBL190513 0.92 PIK3CA (0.95) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
SCHEMBL10268492 0.92 PIK3CA (0.84) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
Pictilisib SCHEMBL29915227 0.92 ABCC4 (1.00) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
SCHEMBL958991 0.92 PIK3CD (0.84) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A
Pictilisib SCHEMBL29370279 0.92 ABCC4 (1.00) PIK3CAPIK3CDPIK3CBPIK3CGPIK3C2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230289-B1 7-(MORPHOLINYL)-2-(N-PIPERAZINYL) METHYL THIENO [2, 3-C]PYRIDINE DERIVATIVES AS ANTICANCER DRUGS NATCO PHARMA LTD (IN) 2019-08-14 EP disclosed
EP-2609192-A1 IN VITRO HEPATIC DIFFERENTIATION Cambridge Enterprise Limited (GB) 2013-07-03 EP disclosed
WO-2012025725-A1 IN VITRO HEPATIC DIFFERENTIATION CAMBRIDGE ENTERPRISE LIMITED (GB) 2012-03-01 WO disclosed